Torrez Lamberti, Mónica F.
Terán, Lucrecia C.
Lopez, Fabián E.
de las Mercedes Pescaretti, María
Delgado, Mónica A.
Funding for this research was provided by:
Universidad Nacional de Chilecito-Argentina (FiCyT N° 2019)
Consejo Nacional de Investigaciones Científicas y Técnicas (PIP N°2015-290)
Universidad Nacional de Tucumán (PIUNT N° D641)
Article History
Received: 22 February 2022
Accepted: 15 June 2022
First Online: 8 July 2022
Declarations
:
: The informed consent from all subjects and/or their legal guardian(s) is not applicable for this study. The two clinical isolates of <i>S</i>. <i>flexneri</i> 2 analyzed here were not specifically isolated to carry out this work. As mentioned throughout this manuscript, these were phenotypically characterized in a previous work (Reference [CitationRef removed]). In accordance with the above, all the authors declare that in this manuscript solely a secondary analysis at the molecular level of two clinical isolates has been carried out.The all methods using here are in accordance with relevant guidelines and regulations, as mentioned in the corresponding Method section. In addition, all protocols carried out in this study has been approved by the appropriate ethical committees of the Ministry of Public Health of the Tucumán Province (Health Research Section-SIPROSA, Expediente Nº 1134-410D-2019); National Administration of Medicines, Food and Medical Technology-Argentina (ANMAT) and of the National Registry of Health Research (ReNIS), which are related to the institutions (Public Hospitals) in which it was performed.All participating members gave informed consent to the work.
: Not applicable.
: The authors declare that they have no competing interests.